Paloma Partners’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-159
Closed -$72K 2160
2020
Q1
$72K Buy
+159
New +$145K ﹤0.01% 1082

Other funds holding LABU

Paloma Partners's LABU Position: Q2 2020 in Review

Paloma Partners sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2020, closing a stake of 159 shares — an estimated $72K sold.

Paloma Partners first reported a position in LABU in Q1 2020 and held it in 1 quarter. The position peaked at $72K in Q1 2020. 20 funds tracked by Wall St. Rank hold LABU as of Q2 2020.

  • Paloma Partners reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2020 after selling out during the quarter.
  • Paloma Partners sold 159 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2020, an estimated $72K.
  • Paloma Partners first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2020 and held it in 1 quarter.
  • Paloma Partners's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $72K in Q1 2020.
  • 20 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2020.

Based on Paloma Partners's 13F filing for Q2 2020, filed 14 Aug 2020.